In the news: Semaglutide prescriptions on the rise but insurance coverage still lacking.
 |
| In the news: Semaglutide prescriptions on the rise but insurance coverage still lacking. It’s common knowledge that a class of diabetic medications called semaglutides, most notably Ozempic, have been increasing in popularity for their purported benefit of weight loss. But did you know how popular? A study from the University of Southern California found that semaglutide prescriptions increased 442% over a 3 year period from 2021 to 2023. These semaglutide prescriptions include the commonly known Ozempic, another diabetic medication Rybelsus, and Wegovy, a heart disease prevention and weight-loss medication. Now, considering that the interrelated conditions of obesity, heart disease, and diabetes sit at the center of US healthcare needs, this increase may not be so surprising. What is perplexing is how to get it covered by insurance. Even as demand for these medications continues to rise, insurance coverage remains an uncertainty and weight loss alone typically does not qualify as an indication. For those relying on cash pay the fees can be heavy: up to $1,350 per month. At Caduceus, we strive to provide our patients with every possible means for the latest advances or developments in health care. For those seeking weight loss consultations, our team of physicians and insurance specialists will make every effort to ensure your medical conditions are covered appropriately. If, for whatever reason, insurance coverage is lacking then Caduceus and its affiliated weight loss program Calypso are offering a cash price for semaglutides starting at $275 per month. Call our dedicated appointment line at 844-807-8558 or self-book from the appointments page at caduceusmedicalgroup.com to reserve an appointment for your annual check-up, cardiac screening, diabetic management, and/or our weight loss programs. Nathaniel DeNicola, MD CMO Caduceus Medical Group |